Skip to main content
About the College
Departments and Centers
Education
Research
Diversity, Equity, and Inclusion
Faculty Affairs and Development
Apply
News
Well-Being Resources
Alumni
About the College
Accreditation
Campuses and Programs
Clinical Partnerships
College Leadership
Dean's Office Contacts
Dean's Welcome
Statement on Racial Justice
Strategic Plan
UK Medicine Magazine
Visit the College of Medicine
Departments and Centers
Basic Science Departments
Clinical Departments
Centers
Education
Office of Biomedical Education
Graduate Medical Education
MD/PhD Program
Medical Student Education
Strategic Plan
Strategic Plan Scorecard
Basic Science Departments
Behavioral Science
Microbiology, Immunology, and Molecular Genetics
Molecular and Cellular Biochemistry
Neuroscience
Pharmacology and Nutritional Sciences
Physiology
Toxicology and Cancer Biology
Clinical Departments
Anesthesiology
Emergency Medicine
Family and Community Medicine
Internal Medicine
Neurology
Neurosurgery
Obstetrics and Gynecology
Ophthalmology
Orthopaedic Surgery and Sports Medicine
Otolaryngology-Head and Neck Surgery
Pathology and Laboratory Medicine
Pediatrics
Physical Medicine and Rehabilitation
Psychiatry
Radiation Medicine
Radiology
Surgery
Urology
Centers
Barnstable Brown Kentucky Diabetes and Obesity Center
Center for Cancer and Metabolism
Center for Clinical and Translational Science
Center for Environmental and Systems Biochemistry
Center for Health Equity Transformation
Center for Microelectrode Technology
Center for Molecular Medicine
Center of Excellence in Rural Health
Center on Drug and Alcohol Research
Center on Trauma and Children
Kentucky Neuroscience Institute
Linda and Jack Gill Heart Institute
Markey Cancer Center
Preclinical Research Center
Saha Aortic Center
Saha Cardiovascular Research Center
Sanders-Brown Center on Aging
Spinal Cord and Brain Injury Research Center
UK-CARES
Apply
For Patients
Giving
My UK
Apply
For Patients
Giving
myUK
Home
News
July 08, 2013
Researchers Investigate Mechanism of Alzheimer's Therapy
email
facebook
linkedin
twitter
Researchers at the University of Kentucky Sanders-Brown Center on Aging, led by faculty member Donna Wilcock, have recently published a new paper in the Journal of Neuroscience detailing an advance in treatment of Alzheimer's disease. Gammagard™ IVIg is a therapy that has been investigated for treatment of Alzheimer's. Despite small clinical studies that have reported efficacy of the approach, the mechanism of action is poorly understood. The UK researchers set out to investigate the mechanism by which the treatment may act in the brain to lower amyloid deposition (amyloid deposits being a key pathology in Alzheimer's). To conduct their investigation, researchers introduced IVIg directly into the brains of mice which carry a human gene causing them to develop amyloid plaques. They found that IVIg lowers amyloid deposits in the brains of the mice over the course of seven days. Their data suggest that the modulation of inflammation in the brain by IVIg is a key event that leads to the reduction in amyloid deposition. The scientists hypothesize that the IVIg acts as an immune modulator, and this immune modulation is responsible for the reductions in amyloid pathology. The data suggests that modulating the immune response in the brain may help ameliorate the Alzheimer’s pathology. Researchers are currently investigating other ways to produce the same modulation of the immune response because the access of IVIg to the brain when administered peripherally is very limited. Other authors on the paper are Tiffany L. Sudduth and Abigail Greenstein of UK. MEDIA CONTACT: Allison Elliott-Shannon, allison.elliott@uky.edu
Recent News
MAY 25, 2023
Diversity and Inclusion Ambassador Spotlight: Kwaku Obeng, MD
MAY 25, 2023
Markey's NCI designation: A decade of impact on cancer research
MAY 24, 2023
Video: The UK College of Medicine Celebrates the Class of 2023
MAY 24, 2023
Radiology Quality and Safety Showcase identifies opportunities for improvement, sustainability
View All News